# Michael Rudnicki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-rudnicki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,699 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 28 |
| i10-index | 50 |
| Last Known Institution | Innsbruck Medical University |
| OpenAlex ID | https://openalex.org/A5050993682 |
| ORCID iD | 0000-0002-7896-2600 |
| Works | 103 |

## Researcher papers

- [Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document](https://scholariq.org/papers/recommendations-for-initiation-and-cessation-of-enzyme-replacement-therapy-in/)
- [Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome](https://scholariq.org/papers/rituximab-in-steroid-dependent-or-frequently-relapsing-idiopathic-nephrotic/)
- [Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease](https://scholariq.org/papers/identification-of-urinary-exosomal-noncoding-rnas-as-novel-biomarkers-in-chronic/)
- [Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss](https://scholariq.org/papers/dickkopf-3-dkk3-in-urine-identifies-patients-with-short-term-risk-of-egfr-loss/)
- [Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients](https://scholariq.org/papers/use-of-sodium-thiosulphate-in-a-multi-interventional-setting-for-the-treatment/)
- [Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils](https://scholariq.org/papers/uremic-toxins-modulate-the-spontaneous-apoptotic-cell-death-and-essential/)
- [Urine proteomics for prediction of disease progression in patients with IgA nephropathy](https://scholariq.org/papers/urine-proteomics-for-prediction-of-disease-progression-in-patients-with-iga/)
- [Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis](https://scholariq.org/papers/risk-factors-associated-with-peritoneal-dialysis-related-peritonitis/)
- [Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review](https://scholariq.org/papers/validity-of-biomarkers-predicting-onset-or-progression-of-nephropathy-in/)
- [Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease](https://scholariq.org/papers/dose-dependent-effect-of-enzyme-replacement-therapy-on-neutralizing-antidrug/)
- [Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies](https://scholariq.org/papers/rituximab-for-treatment-of-membranoproliferative-glomerulonephritis-and-c3/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Innsbruck Medical University](https://scholariq.org/institutions/innsbruck-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
